FDA Approves Eli Lilly’s Test To Help Detect Alzheimer’s Disease
In what could be a big breakthrough, Eli Lilly & Co. has won approval from federal regulators for an imaging test that detects the brain plaque that’s a hallmark of Alzheimer’s disease. The drug maker received the go-ahead from the U.S. Food and Drug Administration (FDA) late last Friday, and..
Read more
